The maker of the Alzheimer's drug Leqembi says its study shows people who had two shots of the drug once weekly had similar results after six months as those who had two IV infusions of the drug ...

Three patients with a muscle-wasting disease died from liver failure after taking the therapy, Ele­vidys, or a similar ...

You’ll receive infusions in a hospital or infusion center. You’ll receive a Tepezza infusion every 3 weeks, for a total of eight doses. Your first two infusions will usually take about 90 minutes.

Infusions were administered at 300 mg at two IV sessions, 2 weeks apart. At week 24, all participants were scheduled to receive 920 mg of ocrelizumab subcutaneously every 24 weeks up to week 96.

The two infusions looked identical, were colorless, and frothed on agitation. In Australia and New Zealand, the pharmacy made up either Intragam P or a placebo solution (normal saline). Syringes ...

Rituxan is given as an IV infusion and contains the active ingredient rituximab. Rituxan Hycela is available in two strengths: 1,400 mg of rituximab and 23,400 units of hyaluronidase human per 11. ...

For the last eight years, Leslie MacGregor from Newton, Massachusetts, has been getting intravenous infusions every month. The treatment is called immunoglobulin, and it bolsters her defective ...

Two studies have examined intravenous vitamin use in fibromyalgia patients. One didn’t turn up any significant improvement in patients who received the infusions.

By Meg Tirrell, CNN (CNN) — The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study ...